The macro picture is hostile to private market valuations. Inflation prints are coming in hot, the rate-cut narrative that priced into private valuations a year ago has evaporated, and the IPO window has effectively shut for small and mid-cap companies. By every traditional rubric, secondary discounts on private shares should be widening across the board.
They are — for most of the market. But not for everyone. SpaceX, Anthropic, Databricks, and Revolut are not just pricing at premiums to their last priced rounds. They are being revalued upward every few months, with each successive round (or secondary clear) printing materially higher than the last. The implied multiples are reminiscent of 2021 SaaS peaks — and in some cases, the dot-com era. Most of the rest of the venture secondary market is going the other way.
This piece walks through the macro setup, what it usually does to venture secondaries, why the top-tier names are decoupling from that gravity, the unsettling parallel to public-market index concentration, and why the bifurcation is more dangerous than the headline narrative suggests.
Key concept
There are not one, but two private markets right now. A broad middle that is repricing downward as macro headwinds compound, and a top tier of roughly a dozen names that the market treats as must-own and prices accordingly. The diligence question is no longer "what's the discount on private market shares?" — it's "which market am I in, and is the gap between the two as wide as it should be?"
The Macro Setup Is Real
Three things have changed in the past few months, and all three point the same direction.
1. Inflation is re-accelerating. The Bureau of Labor Statistics' March 2026 CPI release showed the all-items index up 0.9% month-over-month and 3.3% year-over-year, with energy contributing most of the surge — the gasoline index alone rose 21.2% in March. The producer price index tells the same story from the wholesale side: PPI is up 4.0% year-over-year, the highest reading in three years. Tariff turmoil and the war in the Middle East are the proximate drivers; the macro reality is that the disinflationary trend many models had baked in for 2026 has not held up.
2. The rate-cut narrative has collapsed. The federal funds target range has been at 4.25–4.50% since December 2024. As of late April 2026, CME FedWatch shows roughly a 98% probability that the Fed holds at the April 29–30 meeting, with a meaningful share of commentary now openly considering a hike rather than a cut. A year ago, multiple cuts were priced in for 2026. That repricing matters: discounted-cash-flow models for private companies discount future cash flows at a rate that anchors on the risk-free curve. Higher-for-longer means lower implied valuations, mechanically.
3. The IPO window is closed below mid-cap. Renaissance Capital data shows 45 US IPOs through late April 2026, with the firm's full-year estimate at 200–230 deals. The headline number masks the real story: larger deals are still getting done, but small- and micro-cap activity has effectively stalled. The pipeline contains over 190 mostly-small companies aiming to raise around $6 billion combined — a queue that has been backing up rather than draining. For a shareholder of a mid-cap private company, the path to public-market liquidity has moved from "in the next 12 months" to "we don't know."
The combination is the problem. Each headwind alone is manageable. Together, they compound: longer hold periods + lower implied valuations + fewer buyers willing to underwrite a long-duration position at full price.
What This Usually Does to Venture Secondaries
The mechanics aren't subtle.
Discounts widen. When the risk-free rate rises and stays elevated, the implied DCF value of any long-duration cash flow drops. For private companies whose cash flows are 5–10 years out (or further), the math is unforgiving. Buyers price this in by demanding wider discounts to last priced round.
Buyer pool shrinks. Secondary buyers in this market are mostly funds with their own investors to answer to. When their own LPs are nervous about macro, those funds tighten underwriting and pass on positions they would have taken at a tighter discount six months ago. The marginal buyer's offer drops, and so does the clearing price.
Supply pressure builds. A closed IPO window is a closed exit. Shareholders who have held private equity for 8+ years and were counting on an IPO to provide liquidity are now looking at year 10, 11, 12. The rational response is to seek liquidity through other channels — secondary sales — which adds supply to a market with fewer bidders.
The result on average: wider discounts, slower clearing, and pricing that reflects a less optimistic version of each company's path. This is happening across most of the venture-backed universe right now.
For more on the underlying mechanics of how secondary discounts move, see The Secondary Discount Explained. For shareholders sitting on private equity at companies whose IPO timeline has slipped, see What Happens to Your Equity If Your Company Never IPOs?
The Top Tier Defies Gravity
That's the broad market. A small group of names is moving in the opposite direction — and not by a little.
SpaceX has gone from a $400 billion valuation in July 2025 to an $800 billion tender at $421 per share in December 2025 (per Fortune's reporting) to a $1.25 trillion combined valuation following the February 2026 xAI merger. The company filed confidentially for an IPO on April 1, 2026, with bankers targeting a $1.75 trillion valuation and a June Nasdaq listing — what would be the largest IPO in history. That's a 4x revaluation in roughly nine months.
Anthropic closed a $30 billion Series G in February 2026 at a $380 billion post-money valuation, per the company's official announcement. By April 2026, the implied valuation on secondary markets had reached $1 trillion — nearly tripling in three months — driven by reported annualized revenue jumping from $9 billion at the end of 2025 to $30 billion by March 2026. The same week, Bloomberg reported that Google plans to invest up to $40 billion in Anthropic, with an initial $10 billion committed at a roughly $350 billion valuation. The gap between disciplined primary capital (~$350–380 billion) and secondary trading ($1 trillion) is itself a market signal: secondary buyers are paying nearly 3x what primary investors will pay for the same security. That inversion of the normal primary-vs-secondary relationship deserves attention.
Databricks raised $4 billion in equity plus $2 billion in new debt in December 2025 at a $134 billion valuation, against an annualized revenue run-rate of $5.4 billion growing 65% year-over-year per the company's announcement. The valuation roughly doubled from $62 billion in late 2024. Secondary market activity has held at or near the priced level — broadly consistent with the round, with no meaningful discount.
Revolut closed a secondary share sale in November 2025 at a $75 billion valuation, up from $45 billion in 2024. Per TechCrunch in April 2026, the company is preparing a follow-on secondary in the second half of 2026 targeting a valuation north of $100 billion. Subsequent reporting updated the IPO target to $200 billion — a 125% step up from the November 2025 secondary, on a path that has tripled the valuation in eighteen months while most fintech valuations have compressed.
What these four have in common: dominant or near-dominant market position in their categories, real revenue at material scale, "must-own" status for institutional allocators trying to express AI infrastructure or category-leader exposure, and (for three of the four) direct or adjacent AI revenue. When a fund's investment committee has decided that owning a piece of the AI infrastructure layer is non-negotiable, price sensitivity collapses for the small set of companies that satisfy the mandate.
This is the bifurcation. Below this top tier, the market is repricing per the macro mechanics described above. At the top tier, it is not — or is repricing upward.
The Velocity Problem: Multiples Reminiscent of 2021 (and Sometimes Earlier)
The story isn't just that these names are expensive in absolute terms. It's that they are being repriced upward every few months, with each round (or secondary clear) printing materially higher than the last. Capital is being deployed at the marginal valuation, even as that marginal valuation moves further away from any reasonable interpretation of fundamentals.
Consider the cadence. Anthropic was a $61.5 billion company in March 2025, $183 billion in September 2025, $380 billion in February 2026, and is now trading at an implied $1 trillion in the secondary market in April 2026 — a 16x revaluation in 13 months. SpaceX has gone from $400 billion in July 2025 to a $1.75 trillion IPO target nine months later. Databricks doubled in roughly twelve months. Revolut tripled in eighteen.
What the implied revenue multiples actually are — with every figure dated and sourced so a future reader can see the full context:
Anthropic. Secondary market valuation: $1 trillion (April 2026, per Yahoo Finance). Most recent priced round: $380 billion (Series G, February 2026, per Anthropic's announcement). Google's announced commitment values it at ~$350 billion (April 24, 2026, per Bloomberg). Annualized revenue: $30 billion as of April 7, 2026, per SaaStr's coverage of Anthropic's announcement. Implied multiples (April 2026): ~33x revenue at secondary; ~12x at the price disciplined primary capital (Google) is paying. The 2.75x gap between primary and secondary on the same security in the same week is the central anomaly.
SpaceX. IPO target valuation: $1.75 trillion (April 2026, per CNBC reporting on the confidential filing). 2025 revenue: ~$15.5 billion per Sacra's research note (other estimates range $15–19 billion). Implied multiple at IPO target: ~113x revenue. SaaS comparison fails at this level — this is closer to the multiples paid for narrative leadership at the dot-com peak.
Databricks. Most recent priced round: $134 billion (Series L, December 2025, per Databricks' announcement). Annualized revenue: $5.4 billion (January 2026 quarter, growing 65% YoY, per Databricks). Implied multiple: ~25x revenue. Strong, but defensible against current SaaS comps for a high-growth category leader.
Revolut. Most recent secondary share sale: $75 billion (November 2025). IPO target: $200 billion (April 2026, per CoinDesk reporting). 2024 revenue: $4.0 billion (up 72% from $2.2 billion in 2023, per Revolut's 2024 Annual Report, released April 2025). Implied multiple at IPO target on 2024 revenue: ~50x. With 2025 revenue likely materially higher (Revolut's growth trajectory has been compounding), the forward multiple is lower — but the 2024 figure is the most recent audited number. Notable: Revolut posted $1.4 billion in pre-tax profit in 2024. Unlike most names in this list, it is meaningfully profitable.
The universe of "haves" extends beyond these four, though it remains small. Worth noting two more on the same trajectory:
Ramp. $32 billion valuation (November 2025, per TechCrunch) on $1+ billion ARR (per Ramp's press release) = ~32x revenue. Doubled from $22.5 billion in just three months between July and November 2025.
Rippling. $16.8 billion valuation (May 2025 Series G, per CNBC) on $570 million ARR at the time (per Rippling) = ~30x revenue.
The cluster of top-tier private names trading at 25–50x revenue (with SpaceX at 100x+) is consistent with the 2021 SaaS peak. In 2021, the most expensive public names — Snowflake, Datadog, ServiceNow, others — traded at 30–50x revenue at the highest-multiple days. Those multiples compressed by 60–80% over the following 18 months as the market repriced growth assumptions and as pulled-forward demand became visible. That episode is recent enough that its lessons should still be vivid for most allocators.
The pattern that should worry allocators: the marginal buyer is increasingly the secondary buyer paying a premium to primary, while disciplined primary capital — Google's $350 billion Anthropic commitment is the cleanest current example — prices closer to the prior priced round. When secondary demand pulls valuations far above what primary will support, you have a structural divergence between the people who underwrote the company carefully and the people buying access. That divergence is rarely a stable equilibrium for long.
The Public Market Has the Same Disease
If the bifurcation in private markets feels familiar, that's because the same dynamic has been quietly running in public markets for years.
The S&P 500's top 10 stocks now account for roughly 35.6% of the index by weight, per aggregated April 2026 data. That number peaked above 40% in 2025 — the highest concentration in the index's modern history. From 1990 through 2015, the top 10 weight was stable at 18–23%. It has roughly doubled in a decade.
NVIDIA alone now represents about 8% of the S&P 500. The information technology sector is roughly 35% of the index. Seven of the top 10 companies by market cap are technology firms. And the gap between weight and earnings tells the relevant story: in 2025, the top 10 stocks were 41% of the index by weight but only 32% of its earnings. The premium is real; it is not earned by current cash flow.
The HHI concentration metric reads at 185 versus a 5-year average of 142. The "effective number" of stocks in the index — adjusting for concentration — is 54, despite the index nominally holding 503. An investor in the S&P 500 today is closer to owning a 54-stock concentrated portfolio than a diversified market basket, and that 54 is dominated by a handful of names whose narratives drive the entire index.
The dynamic is structurally identical to what is happening in venture secondaries. A mandate to own the category leader, applied across a large pool of capital, drives that leader's price up faster than any reasonable model of fundamentals. The capital crowds in. The remaining pool — companies outside the top tier — gets less attention, less capital, and a wider discount to whatever the headline narrative implies their value should be.
The mental error to avoid: treating the index (or "the private market") as the average of its components. The average is being pulled by a handful of names that look very little like everything else in the basket.
Why This Is Dangerous
Concentration at this level is not, by itself, a prediction of imminent reversal. It is, however, a configuration with strong historical precedent — and the precedents are not pleasant.
The Nifty Fifty episode of the early 1970s saw a similar dynamic: a small group of "one-decision" growth stocks attracted disproportionate institutional capital, traded at premium multiples to the rest of the market, and were widely characterized as must-own positions for any serious portfolio. Through 1973–1974, those names underperformed the broader market by roughly 50% from peak to trough. The mandate that drove them up did not protect them on the way down.
The dot-com peak in 1999–2000 saw the top 10 S&P 500 names reach historic concentration on the back of internet-era category-leadership narratives. The subsequent reversal was specific to the concentrated names — the broad market drew down materially less than the leaders.
The pattern is general. When a small set of names carries an outsized share of the market's value because the market has decided they are a one-way bet, the eventual reversal is asymmetric: the leaders fall harder than the average, because the premium that the mandate built into their prices has nowhere to go but down when the mandate breaks.
This is the moment Warren Buffett's most-cited rule speaks to:
"Be fearful when others are greedy, and be greedy when others are fearful."
— Warren Buffett, in his 1986 letter to Berkshire Hathaway shareholders, reiterated and acted on in a New York Times op-ed during the 2008 financial crisis.
The point is not to predict that any specific top-tier private company is in for a correction. It is to notice that the conditions that produce one — concentration, a mandate-driven premium, narrative-driven price formation — are present in both public indexes and the top tier of private secondaries simultaneously. Allocators paying premium prices on this top tier are paying for a narrative whose price the broader market is already eroding for everyone outside the top tier. That asymmetry has historically been the warning sign, not the all-clear.
⚠️ Diversification doesn't disappear because it stops being convenient. It disappears because the basket of names that used to provide it has collapsed into a handful of correlated bets. The broad index — public or private — is doing less of the work it's supposed to do than at any point in living memory.
What This Means for Shareholders and Allocators
For shareholders sitting on private equity at a company outside the top tier, the implication is direct. The discount you would have been quoted six months ago has gotten wider. The clearing time has gotten longer. The IPO that was your default exit has receded. The decision is no longer "should I sell now or wait for the IPO" — it is "should I take this discount, or wait through an environment that is currently moving against me."
For shareholders at companies in the top tier, the inverse is true. Pricing has held or improved. The question becomes whether the premium the market is paying you is more than the value of holding through the eventual catalyst — for several of these names, an IPO that is plausibly coming in 2026 or 2027.
For allocators, the central question is whether buying into the top tier at current prices is a continuation of a trend that has rewarded participation for years, or the late stages of a concentration that history suggests reverses asymmetrically. The honest answer is that nobody knows. What is knowable is that the premium is real, the concentration is at historic levels, and the mental model of "the private market is repricing down because of macro" is flatly wrong for these specific names. Whatever you decide, decide it knowing that you are buying a bet on the durability of a mandate, not a discount to fundamentals.
The Buffett line is not a recommendation. It is an observation about how human capital allocation behaves under exactly these conditions, and how it has behaved before.
Have questions about a specific position?
We're happy to share our perspective.
If you're a shareholder evaluating whether to seek liquidity in this market, or an allocator weighing exposure to top-tier private names, we'd encourage you to reach out. We're always happy to share our thoughts — no commitment required.
Get in touch →contact@earlyasset.com · We typically respond within one business day
Earlyasset, Inc. does not provide investment advice and is not a registered investment adviser. Pricing estimates are algorithmic and do not constitute an offer to buy or sell securities. All transactions respect the company's right of first refusal (ROFR) and any transfer restrictions in your equity agreements. Direct liquidity is provided by Earlyasset Capital, LLC, a separate entity from Earlyasset, Inc.
Source note: Macro and inflation data are sourced from the U.S. Bureau of Labor Statistics (CPI release for March 2026, PPI release for March 2026), the CME Group's FedWatch tool (rate probabilities as of late April 2026), and Renaissance Capital's 2026 IPO market data. Company-specific valuations, revenue figures, and funding events are sourced from each company's own announcements and public reporting current as of late April 2026 — including SpaceX's December 2025 tender (Fortune), February 2026 xAI merger, and April 1, 2026 confidential IPO filing (CNBC); Anthropic's February 2026 Series G announcement, the April 2026 $1 trillion secondary market reporting (Yahoo Finance), the April 7, 2026 $30 billion ARR announcement (covered by SaaStr), and the April 24, 2026 Bloomberg report on Google's planned $40 billion investment; Databricks' December 2025 Series L announcement; Revolut's November 2025 secondary, the April 21, 2026 reports on the $200 billion IPO target (TechCrunch, CoinDesk), and the 2024 Annual Report (released April 2025) for revenue figures; Ramp's November 2025 funding announcement (TechCrunch and Ramp's press release); and Rippling's May 2025 Series G (CNBC). Revenue multiple calculations are derived from publicly reported headline valuations divided by publicly reported revenue or ARR at the most recent reported point; they are illustrative arithmetic, not Earlyasset's view of fair value for any specific company. Multiples reflect a snapshot at the time of writing and will change as revenue grows, valuations move, or new figures are reported. S&P 500 concentration figures are sourced from public market-data aggregators current as of April 2026. Earlyasset is not affiliated with any of the companies named in this article and has no non-public information about any of them. References to historical market episodes (Nifty Fifty, dot-com peak, 2021 SaaS peak) are illustrative; past performance does not predict future results. The Warren Buffett quotation is from the 1986 Berkshire Hathaway shareholder letter, reiterated in his October 17, 2008 New York Times op-ed.
Not investment advice. This article is general analytical content. It is not a recommendation to buy, sell, or hold any specific security. Shareholders considering a sale, and allocators considering an investment, should consult their own legal, tax, and financial advisors before acting.